Skip to main content
×
Home
    • Aa
    • Aa

Implications of modifying the duration requirement of generalized anxiety disorder in developed and developing countries

  • S. Lee (a1), A. Tsang (a2), A. M. Ruscio (a3), J. M. Haro (a4), D. J. Stein (a5), J. Alonso (a6), M. C. Angermeyer (a7), E. J. Bromet (a8), K. Demyttenaere (a9), G. de Girolamo (a10), R. de Graaf (a11), O. Gureje (a12), N. Iwata (a13), E. G. Karam (a14), J.-P. Lepine (a15), D. Levinson (a16), M. E. Medina-Mora (a17), M. A. Oakley Browne (a18), J. Posada-Villa (a19) and R. C. Kessler (a20)...
Abstract
Background

A number of western studies have suggested that the 6-month duration requirement of generalized anxiety disorder (GAD) does not represent a critical threshold in terms of onset, course, or risk factors of the disorder. No study has examined the consequences of modifying the duration requirement across a wide range of correlates in both developed and developing countries.

Method

Population surveys were carried out in seven developing and 10 developed countries using the WHO Composite International Diagnostic Interview (total sample=85 052). Prevalence and correlates of GAD were compared across mutually exclusive GAD subgroups defined by different minimum duration criteria.

Results

Lifetime prevalence estimates for GAD lasting 1 month, 3 months, 6 months and 12 months were 7.5%, 5.2%, 4.1% and 3.0% for developed countries and 2.7%, 1.8%, 1.5% and 1.2% for developing countries, respectively. There was little difference between GAD of 6 months' duration and GAD of shorter durations (1–2 months, 3–5 months) in age of onset, symptom severity or persistence, co-morbidity or impairment. GAD lasting ⩾12 months was the most severe, persistently symptomatic and impaired subgroup.

Conclusions

In both developed and developing countries, the clinical profile of GAD is similar regardless of duration. The DSM-IV 6-month duration criterion excludes a large number of individuals who present with shorter generalized anxiety episodes which may be recurrent, impairing and contributory to treatment-seeking. Future iterations of the DSM and ICD should consider modifying the 6-month duration criterion so as to better capture the diversity of clinically salient anxiety presentations.

Copyright
Corresponding author
*Address for correspondence: Professor S. Lee, Director, Hong Kong Mood Disorders Center, 7A, Block E, Staff Quarters, Prince of Wales Hospital, Shatin, NT, Hong Kong. (Email: singlee@cuhk.edu.hk)
References
Hide All
Angst J, Gamma A, Joseph Bienvenu O, Eaton WW, Ajdacic V, Eich D, Rössler W (2006). Varying temporal criteria for generalized anxiety disorder: prevalence and clinical characteristics in a young age cohort. Psychological Medicine 36, 12831292.
APA (1980). Diagnostic and Statistical Manual of Mental Disorders, 3rd edn. American Psychiatric Association: Washington, DC.
APA (1987). Diagnostic and Statistical Manual of Mental Disorders, 3rd edn, revised. American Psychiatric Association: Washington, DC.
APA (2000). Diagnostic and Statistical Manual of Mental Disorders, 4th edn, text revision. American Psychiatric Association: Washington, DC.
Bienvenu OJ, Nestadt G, Eaton WW (1998). Characterizing generalized anxiety: temporal and symptomatic thresholds. Journal of Nervous and Mental Disease 186, 5156.
Breslau N, Davis GC (1985). DSM-III generalized anxiety disorder: an empirical investigation of more stringent criteria. Psychiatry Research 15, 231238.
Brown TA, Di Nardo PA, Lehman CL, Campbell LA (2001). Reliability of DSM-IV anxiety and mood disorders: implications for the classification of emotional disorders. Journal of Abnormal Psychology 110, 4958.
Carter RM, Wittchen HU, Pfister H, Kessler RC (2001). One-year prevalence of subthreshold and threshold DSM-IV generalized anxiety disorder in a nationally representative sample. Depression and Anxiety 13, 7888.
Chang SM, Hahm BJ, Lee JY, Shin MS, Jeon HJ, Hong JP, Lee HB, Lee DW, Cho MJ (2008). Cross-national difference in the prevalence of depression caused by the diagnostic threshold. Journal of Affective Disorders 106, 159167.
Demyttenaere K, Bruffaerts R, Posada-Villa J, Gasquet I, Kovess V, Lepine JP, Angermeyer MC, Bernert S, de Girolamo G, Morosini P, Polidori G, Kikkawa T, Kawakami N, Ono Y, Takeshima T, Uda H, Karam EG, Fayyad JA, Karam AN, Mneimneh ZN, Medina-Mora ME, Borges G, Lara C, de Graaf R, Ormel J, Gureje O, Shen Y, Huang Y, Zhang M, Alonso J, Haro JM, Vilagut G, Bromet EJ, Gluzman S, Webb C, Kessler RC, Merikangas KR, Anthony JC, Von Korff MR, Wang PS, Brugha TS, Aguilar-Gaxiola S, Lee S, Heeringa S, Pennell BE, Zaslavsky AM, Ustun TB, Chatterji S, WHO World Mental Health Survey Consortium (2004). Prevalence, severity, and unmet need for treatment of mental disorders in the World Health Organization World Mental Health Surveys. Journal of the American Medical Association 291, 25812590.
Feighner JP, Robins E, Guze SB, Woodruff RA Jr., Winokur G, Munoz R (1972). Diagnostic criteria for use in psychiatric research. Archives of General Psychiatry 26, 5763.
First MB, Spitzer RL, Gibbon M, Williams JBW (2002). Structured Clinical Interview for DSM-IV Axis I Disorders, Research Version, Non-patient Edition (SCID-I/NP). Biometrics Research, New York State Psychiatric Institute: New York.
Gureje O, Lasebikan VO, Kola L, Makanjuola VA (2006). Lifetime and 12-month prevalence of mental disorders in the Nigerian Survey of Mental Health and Well-Being. British Journal of Psychiatry 188, 465471.
Halli SS, Vaninadha Rao K (1992). Advanced Techniques of Population Analysis. Plenum Press: New York.
Haro JM, Arbabzadeh-Bouchez S, Brugha TS, de Girolamo G, Guyer ME, Jin R, Lepine JP, Mazzi F, Reneses B, Vilagut G, Sampson NA, Kessler RC (2006). Concordance of the Composite International Diagnostic Interview version 3.0 (CIDI 3.0) with standardized clinical assessments in the WHO World Mental Health surveys. International Journal of Methods in Psychiatric Research 15, 167180.
Hettema JM, Prescott CA, Kendler KS (2001). A population-based twin study of generalized anxiety disorder in men and women. Journal of Nervous and Mental Disease 189, 413420.
Heuzenroeder L, Donnelly M, Haby MM, Mihalopoulos C, Rossell R, Carter R, Andrews G, Vos T (2004). Cost-effectiveness of psychological and pharmacological interventions for generalized anxiety disorder and panic disorder. Australia and New Zealand Journal of Psychiatry 38, 602612.
Kendler KS, Neale MC, Kessler RC, Heath AC, Eaves LJ (1992). Generalized anxiety disorder in women. A population-based twin study. Archives of General Psychiatry 49, 267272.
Kendler KS, Neale MC, Kessler RC, Heath AC, Eaves LJ (1994). Clinical characteristics of familial generalized anxiety disorder. Anxiety 1, 186191.
Kessler RC, Andrade LH, Bijl RV, Offord DR, Demler OV, Stein DJ (2002). The effects of comorbidity on the onset and persistence of generalized anxiety disorder in the ICPE surveys. Psychological Medicine 32, 12131225.
Kessler RC, Brandenburg N, Lane M, Roy-Byrne P, Stang PD, Stein DJ, Wittchen HU (2005). Rethinking the duration requirement for generalized anxiety disorder: evidence from the National Comorbidity Survey Replication. Psychological Medicine 35, 10731082.
Kessler RC, Ustun TB (2004). The World Mental Health (WMH) Survey Initiative Version of the World Health Organization (WHO) Composite International Diagnostic Interview (CIDI). International Journal of Methods in Psychiatric Research 13, 93121.
Knauper B, Cannell CF, Schwarz N, Bruce ML, Kessler RC (1999). Improving the accuracy of major depression age of onset reports in the US National Comorbidity Survey. International Journal of Methods in Psychiatric Research 8, 3948.
Lee S, Tsang A, Chui H, Kwok K, Cheung E (2007 a). A community epidemiological survey of generalized anxiety disorder in Hong Kong. Community Mental Health Journal 43, 305319.
Lee S, Tsang A, Zhang MY, Huang YQ, He YL, Liu ZR, Shen YC, Kessler RC (2007 b). Lifetime prevalence and inter-cohort variation in DSM-IV disorders in metropolitan China. Psychological Medicine 37, 6171.
Leon AC, Olfson M, Portera L, Farber L, Sheehan DV (1997). Assessing psychiatric impairment in primary care with the Sheehan Disability Scale. International Journal of Psychiatry in Medicine 27, 93105.
Maier W, Gansicke M, Freyberger HJ, Linz M, Heun R, Lecrubier Y (2000). Generalized anxiety disorder (ICD-10) in primary care from a cross-cultural perspective: a valid diagnostic entity? Acta Psychiatrica Scandinavica 101, 2936.
Rickels K, Rynn M (2001). Overview and clinical presentation of generalized anxiety disorder. Psychiatric Clinics of North America 24, 117.
Ruscio AM (2002). Delimiting the boundaries of generalized anxiety disorder: differentiating high worriers with and without GAD. Journal of Anxiety Disorders 16, 377400.
Ruscio AM, Chiu WT, Roy-Byrne P, Stang PE, Stein DJ, Wittchen HU, Kessler RC (2007). Broadening the definition of generalized anxiety disorder: effects on prevalence and associations with other disorders in the National Comorbidity Survey Replication. Journal of Anxiety Disorders 21, 662676.
Shen YC, Zhang MY, Huang YQ, He YL, Liu ZR, Cheng H, Tsang A, Lee S, Kessler RC (2006). Twelve-month prevalence, severity, and unmet need for treatment of mental disorders in metropolitan China. Psychological Medicine 36, 257267.
Slade T, Andrews G (2001). DSM-IV and ICD-10 generalized anxiety disorder: discrepant diagnoses and associated disability. Social Psychiatry and Psychiatric Epidemiology 36, 4551.
Spitzer RL, Williams JBW (1984). Diagnostic issues in the DSM-III classification of the anxiety disorders. In Psychiatry Updates: The American Psychiatric Association Annual Review Volume III (ed. Grinspoon L.), pp. 392402. American Psychiatric Press: Washington, DC.
United Nations Development Programme (2004). Human Development Report 2004: Cultural Liberty in Today's Diverse World. United Nations Development Programme: New York.
Wang PS, Angermeyer MC, Borges G, Bruffaerts R, Tat Chiu W, de Girolamo G, Fayyad J, Gureje O, Haro JM, Huang Y, Kessler RC, Kovess V, Levinson D, Nakane Y, Oakley Brown MA, Ormel JH, Posada-Villa J, Aguilar-Gaxiola S, Alonso J, Lee S, Heeringa S, Pennell BE, Chatterji S, Ustun TB (2007). Delay and failure in treatment seeking after first onset of mental disorders in the World Health Organization's World Mental Health Survey Initiative. World Psychiatry 6, 177185.
Wolter KM (1985). Introduction to Variance Estimation. Springer-Verlag: New York.
WHO (1978). Mental Disorders: Glossary and Guide to their Classification in Accordance with the Ninth Revision of the International Classification of Diseases. World Health Organization: Geneva.
WHO (1993). The ICD-10 Classification of Mental and Behavioural Disorders. World Health Organization: Geneva.
Yonkers KA, Dyck IR, Warshaw M, Keller MB (2000). Factors predicting the clinical course of generalised anxiety disorder. British Journal of Psychiatry 176, 544549.
Yonkers KA, Warshaw MG, Massion AO, Keller MB (1996). Phenomenology and course of generalised anxiety disorder. British Journal of Psychiatry 168, 308313.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Psychological Medicine
  • ISSN: 0033-2917
  • EISSN: 1469-8978
  • URL: /core/journals/psychological-medicine
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Keywords:

Metrics

Full text views

Total number of HTML views: 1
Total number of PDF views: 21 *
Loading metrics...

Abstract views

Total abstract views: 185 *
Loading metrics...

* Views captured on Cambridge Core between September 2016 - 22nd October 2017. This data will be updated every 24 hours.